Margaret E. Gatti-mays
Center for Cancer Research
National Cancer Institute
United States of America
"Dr Gatti-Mays earned a Bachelors of Science in Biology from Trinity College (Hartford, CT) in 2005 and a Masters in Public Health in Epidemiology at the Rollins School of Public Health, Emory University (Atlanta, GA). She received a M.D. from Georgetown University School of Medicine (Washington, DC) in 2011. Following graduation in 2014 from an internal medicine residency at Medstar Georgetown University Hospital (Washington,DC), she was selected to serve as Chief Resident (2014-2015). In 2017, she completed fellowship in medical oncology at NCI and then joined the Laboratory of Tumor Immunology and Biology as a Staff Clinician. Dr. Gatti-Mays is board certified in internal medicine and is board eligible for medical oncology. She is a member of the Alpha Omega Alpha Medical Honor Society."
breast cancer, immunotherapy, therapeutic cancer vaccines, health literacy
Gatti-Mays ME, Redman JM, Collins JM, Bilusic M. Cancer Vaccines: Enhanced Immunogenic Modulation through Therapeutic Combinations. Human Vaccines & Immunotherapeutics. 2017 Aug 19(just-accepted):00-.
Gatti-Mays ME, Manion M, Bowen LN, Brown GT, Danner RL, Khan O, Nath A, Battiwalla M, Barrett AJ, Ito S. Toxoplasmosis encephalitis with immune-reconstitution inflammatory syndrome in an allogeneic stem cell transplant patient: a case report. Bone marrow transplantation. 2016 Dec 1;51(12):1622-4.
Gatti-Mays ME, Venzon D, Galbo CE, Singer A, Reynolds J, Makaiou E, Kallakury B, Heckman-Stoddard BM, Korde L, Isaacs C, Warren R. Exemestane use in postmenopausal women at high risk for invasive breast cancer: evaluating biomarkers of efficacy and safety. Cancer Prevention Research. 2016 Jan 12:canprevres-0269.